Inventiva (NASDAQ:IVA) Trading Down 2.8%

Inventiva S.A. (NASDAQ:IVAGet Rating)’s share price dropped 2.8% during trading on Tuesday . The stock traded as low as $8.81 and last traded at $9.04. Approximately 3,159 shares were traded during trading, a decline of 45% from the average daily volume of 5,713 shares. The stock had previously closed at $9.30.

The company has a quick ratio of 5.04, a current ratio of 5.06 and a debt-to-equity ratio of 0.10. The business’s fifty day moving average is $10.33 and its 200 day moving average is $12.04.

Inventiva Company Profile (NASDAQ:IVA)

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH.

See Also

Receive News & Ratings for Inventiva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inventiva and related companies with MarketBeat.com's FREE daily email newsletter.